Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.13 USD | -3.31% | +9.48% | -7.24% |
May. 28 | Sector Update: Health Care Stocks Retreat Tuesday Afternoon | MT |
May. 28 | Corcept Therapeutics Says Phase 3 Hypercortisolism Trial Meets Primary Endpoint; Shares Advance | MT |
Financials (USD)
Sales 2024 * | 634M | Sales 2025 * | 717M | Capitalization | 3.14B |
---|---|---|---|---|---|
Net income 2024 * | 106M | Net income 2025 * | 152M | EV / Sales 2024 * | 4.95 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.38 x |
P/E ratio 2024 * |
32.6
x | P/E ratio 2025 * |
23
x | Employees | 352 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.18% |
Latest transcript on Corcept Therapeutics Incorporated
1 day | -3.31% | ||
1 week | +9.48% | ||
Current month | -0.13% | ||
1 month | +20.23% | ||
3 months | +25.23% | ||
6 months | +16.02% | ||
Current year | -7.24% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 98-05-12 |
Atabak Mokari
DFI | Director of Finance/CFO | 47 | 21-02-28 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 98-05-12 |
Gregg Alton
BRD | Director/Board Member | 58 | 20-03-11 |
George Baker
BRD | Director/Board Member | 81 | 98-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.71% | 28 M€ | -1.00% | ||
0.30% | 43 M€ | +4.17% | ||
0.27% | 25 M€ | -2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 30.17 | -3.33% | 1,374,270 |
24-05-30 | 31.21 | -1.01% | 997,703 |
24-05-29 | 31.53 | -0.25% | 1,209,410 |
24-05-28 | 31.61 | +14.86% | 3,604,324 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.24% | 3.14B | |
+40.73% | 739B | |
+31.40% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.66% | 240B | |
+9.25% | 210B | |
-5.07% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- CORT Stock